MAPT and Alzheimer disease: Passive immunization of AD transgenic mice with antibodies against tau, resulted in a reduction in the total Aβ burden, indicating a potential cross-talk between soluble tau and the amyloidogenic pathway, which gives rise to Aβ (Dai et al., 2017).